Biotech ETF Update
Gary S. Morrow | Sep 04, 2020 02:35PM ET
The Biotech ETF (NYSE:XBI) is testing a major support zone as the week comes to an end. This key area includes the initial all-time high set back in 2018 and the 2019 peak. Also beefing up the lower band is an upward sloping 200-day moving average. Just above the 200D is the 1/3 retracement level of the rally off the March lows. At midday the XBI is rebounding indicating there is buying interest near $101.00.
This major support zone runs from $101.50 down to $98.00.
The top XBI holdings:
| Novavax (NASDAQ:NVAX) Inc |
| InVitae Corp (NYSE:NVTA) |
| Aimmune Therapeutics Inc (NASDAQ:AIMT) |
| Momenta Pharmaceuticals Inc (NASDAQ:MNTA) |
| Natera Inc (NASDAQ:NTRA) |
| Emergent Biosolutions Inc (NYSE:EBS) |
| TG Therapeutics Inc (NASDAQ:TGTX) |
| Sage Therapeutic (NASDAQ:SAGE) |
| Mirati Ther (NASDAQ:MRTX) |
| Immunomedics Inc (NASDAQ:IMMU) |
Note: We are long the XBI in some managed accounts. We are looking to add to positions.
Gary S. Morrow's original post can been read here.
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.